1. Home
  2. TDAY vs VIR Comparison

TDAY vs VIR Comparison

Compare TDAY & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TDAY

USA TODAY Co. Inc.

N/A

Current Price

$6.59

Market Cap

866.5M

ML Signal

N/A

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$8.96

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TDAY
VIR
Founded
2013
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
866.5M
1.0B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
TDAY
VIR
Price
$6.59
$8.96
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$10.00
$29.30
AVG Volume (30 Days)
1.4M
2.5M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$131.58
P/E Ratio
$10.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.54
$4.16
52 Week High
$6.36
$10.91

Technical Indicators

Market Signals
Indicator
TDAY
VIR
Relative Strength Index (RSI) 64.63 62.64
Support Level $5.61 $4.88
Resistance Level N/A N/A
Average True Range (ATR) 0.28 0.53
MACD 0.02 0.17
Stochastic Oscillator 84.14 51.60

Price Performance

Historical Comparison
TDAY
VIR

About TDAY USA TODAY Co. Inc.

USA Today Co Inc is a diversified media company with expansive reach at the national and local level, dedicated to empowering and enriching communities. It prioritizes a digital-first approach, focusing on audience growth and engagement while diversifying revenue streams. Through its trusted brands, including the USA TODAY NETWORK, comprised of the national publication, USA TODAY, and local media organizations, including a network of local properties, in the United States, and Newsquest, a wholly-owned subsidiary operating in the United Kingdom, provide essential journalism, local content, and digital experiences to audiences and businesses. Its digital marketing solutions brand, LocaliQ, supports small and medium-sized businesses with digital marketing products and solutions.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: